Global Aptamer CDMO Market Growth (Status and Outlook) 2026-2032

January 2026 | 101 pages | ID: G4290435FA72EN
LP Information

Abstracts

The global Aptamer CDMO market size is predicted to grow from US$ 215 million in 2025 to US$ 510 million in 2032; it is expected to grow at a CAGR of 13.4% from 2026 to 2032.

Aptamers are oligonucleotide sequences that are obtained through artificial screening and can specifically bind to target molecules. They have high specificity and affinity, and are easy to synthesize and modify, so they have broad application prospects in drug research and development. Aptamer CDMO refers to the CDMO field, which focuses on the research and development and production services of aptamer-related drugs.

United States market for Aptamer CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Aptamer CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Aptamer CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Aptamer CDMO players cover AMSBIO, Aptagen, Aptamer Group, PORTON, Base Pair, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Aptamer CDMO Industry Forecast? looks at past sales and reviews total world Aptamer CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Aptamer CDMO sales for 2026 through 2032. With Aptamer CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aptamer CDMO industry.

This Insight Report provides a comprehensive analysis of the global Aptamer CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Aptamer CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Aptamer CDMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aptamer CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aptamer CDMO.

This report presents a comprehensive overview, market shares, and growth opportunities of Aptamer CDMO market by product type, application, key players and key regions and countries.

Segmentation by Type:

• RNA Aptamer CDMO
• DNA Aptamer CDMO
• Others

Segmentation by Application:

• Scientific Research
• Medical Treatment
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AMSBIO
• Aptagen
• Aptamer Group
• PORTON
• Base Pair
• Base Pair Biotechnologies
• Cambio
• CD Bioparticles
• Creative Biolabs
• Eurogentec
• Novaptech

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Aptamer CDMO Market Size (2021-2032)
  2.1.2 Aptamer CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Aptamer CDMO by Country/Region (2021, 2025 & 2032)
2.2 Aptamer CDMO Segment by Type
  2.2.1 RNA Aptamer CDMO
  2.2.2 DNA Aptamer CDMO
  2.2.3 Others
  2.2.4 Aptamer CDMO Market Size by Type
    2.2.4.1 Aptamer CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Aptamer CDMO Market Size Market Share by Type (2021-2026)
2.3 Aptamer CDMO Segment by Application
  2.3.1 Scientific Research
  2.3.2 Medical Treatment
  2.3.3 Others
  2.3.4 Aptamer CDMO Market Size by Application
    2.3.4.1 Aptamer CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Aptamer CDMO Market Size Market Share by Application (2021-2026)

3 APTAMER CDMO MARKET SIZE BY PLAYER

3.1 Aptamer CDMO Market Size Market Share by Player
  3.1.1 Global Aptamer CDMO Revenue by Player (2021-2026)
  3.1.2 Global Aptamer CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Aptamer CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 APTAMER CDMO BY REGION

4.1 Aptamer CDMO Market Size by Region (2021-2026)
4.2 Global Aptamer CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Aptamer CDMO Market Size Growth (2021-2026)
4.4 APAC Aptamer CDMO Market Size Growth (2021-2026)
4.5 Europe Aptamer CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Aptamer CDMO Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Aptamer CDMO Market Size by Country (2021-2026)
5.2 Americas Aptamer CDMO Market Size by Type (2021-2026)
5.3 Americas Aptamer CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Aptamer CDMO Market Size by Region (2021-2026)
6.2 APAC Aptamer CDMO Market Size by Type (2021-2026)
6.3 APAC Aptamer CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Aptamer CDMO Market Size by Country (2021-2026)
7.2 Europe Aptamer CDMO Market Size by Type (2021-2026)
7.3 Europe Aptamer CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Aptamer CDMO by Region (2021-2026)
8.2 Middle East & Africa Aptamer CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Aptamer CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL APTAMER CDMO MARKET FORECAST

10.1 Global Aptamer CDMO Forecast by Region (2027-2032)
  10.1.1 Global Aptamer CDMO Forecast by Region (2027-2032)
  10.1.2 Americas Aptamer CDMO Forecast
  10.1.3 APAC Aptamer CDMO Forecast
  10.1.4 Europe Aptamer CDMO Forecast
  10.1.5 Middle East & Africa Aptamer CDMO Forecast
10.2 Americas Aptamer CDMO Forecast by Country (2027-2032)
  10.2.1 United States Market Aptamer CDMO Forecast
  10.2.2 Canada Market Aptamer CDMO Forecast
  10.2.3 Mexico Market Aptamer CDMO Forecast
  10.2.4 Brazil Market Aptamer CDMO Forecast
10.3 APAC Aptamer CDMO Forecast by Region (2027-2032)
  10.3.1 China Aptamer CDMO Market Forecast
  10.3.2 Japan Market Aptamer CDMO Forecast
  10.3.3 Korea Market Aptamer CDMO Forecast
  10.3.4 Southeast Asia Market Aptamer CDMO Forecast
  10.3.5 India Market Aptamer CDMO Forecast
  10.3.6 Australia Market Aptamer CDMO Forecast
10.4 Europe Aptamer CDMO Forecast by Country (2027-2032)
  10.4.1 Germany Market Aptamer CDMO Forecast
  10.4.2 France Market Aptamer CDMO Forecast
  10.4.3 UK Market Aptamer CDMO Forecast
  10.4.4 Italy Market Aptamer CDMO Forecast
  10.4.5 Russia Market Aptamer CDMO Forecast
10.5 Middle East & Africa Aptamer CDMO Forecast by Region (2027-2032)
  10.5.1 Egypt Market Aptamer CDMO Forecast
  10.5.2 South Africa Market Aptamer CDMO Forecast
  10.5.3 Israel Market Aptamer CDMO Forecast
  10.5.4 Turkey Market Aptamer CDMO Forecast
10.6 Global Aptamer CDMO Forecast by Type (2027-2032)
10.7 Global Aptamer CDMO Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Aptamer CDMO Forecast

11 KEY PLAYERS ANALYSIS

11.1 AMSBIO
  11.1.1 AMSBIO Company Information
  11.1.2 AMSBIO Aptamer CDMO Product Offered
  11.1.3 AMSBIO Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 AMSBIO Main Business Overview
  11.1.5 AMSBIO Latest Developments
11.2 Aptagen
  11.2.1 Aptagen Company Information
  11.2.2 Aptagen Aptamer CDMO Product Offered
  11.2.3 Aptagen Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Aptagen Main Business Overview
  11.2.5 Aptagen Latest Developments
11.3 Aptamer Group
  11.3.1 Aptamer Group Company Information
  11.3.2 Aptamer Group Aptamer CDMO Product Offered
  11.3.3 Aptamer Group Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Aptamer Group Main Business Overview
  11.3.5 Aptamer Group Latest Developments
11.4 PORTON
  11.4.1 PORTON Company Information
  11.4.2 PORTON Aptamer CDMO Product Offered
  11.4.3 PORTON Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 PORTON Main Business Overview
  11.4.5 PORTON Latest Developments
11.5 Base Pair
  11.5.1 Base Pair Company Information
  11.5.2 Base Pair Aptamer CDMO Product Offered
  11.5.3 Base Pair Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Base Pair Main Business Overview
  11.5.5 Base Pair Latest Developments
11.6 Base Pair Biotechnologies
  11.6.1 Base Pair Biotechnologies Company Information
  11.6.2 Base Pair Biotechnologies Aptamer CDMO Product Offered
  11.6.3 Base Pair Biotechnologies Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Base Pair Biotechnologies Main Business Overview
  11.6.5 Base Pair Biotechnologies Latest Developments
11.7 Cambio
  11.7.1 Cambio Company Information
  11.7.2 Cambio Aptamer CDMO Product Offered
  11.7.3 Cambio Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Cambio Main Business Overview
  11.7.5 Cambio Latest Developments
11.8 CD Bioparticles
  11.8.1 CD Bioparticles Company Information
  11.8.2 CD Bioparticles Aptamer CDMO Product Offered
  11.8.3 CD Bioparticles Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 CD Bioparticles Main Business Overview
  11.8.5 CD Bioparticles Latest Developments
11.9 Creative Biolabs
  11.9.1 Creative Biolabs Company Information
  11.9.2 Creative Biolabs Aptamer CDMO Product Offered
  11.9.3 Creative Biolabs Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Creative Biolabs Main Business Overview
  11.9.5 Creative Biolabs Latest Developments
11.10 Eurogentec
  11.10.1 Eurogentec Company Information
  11.10.2 Eurogentec Aptamer CDMO Product Offered
  11.10.3 Eurogentec Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Eurogentec Main Business Overview
  11.10.5 Eurogentec Latest Developments
11.11 Novaptech
  11.11.1 Novaptech Company Information
  11.11.2 Novaptech Aptamer CDMO Product Offered
  11.11.3 Novaptech Aptamer CDMO Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Novaptech Main Business Overview
  11.11.5 Novaptech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Aptamer CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Aptamer CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of RNA Aptamer CDMO
Table 4. Major Players of DNA Aptamer CDMO
Table 5. Major Players of Others
Table 6. Aptamer CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Aptamer CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Aptamer CDMO Market Size Market Share by Type (2021-2026)
Table 9. Aptamer CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Aptamer CDMO Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Aptamer CDMO Market Size Market Share by Application (2021-2026)
Table 12. Global Aptamer CDMO Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Aptamer CDMO Revenue Market Share by Player (2021-2026)
Table 14. Aptamer CDMO Key Players Head office and Products Offered
Table 15. Aptamer CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Aptamer CDMO Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Aptamer CDMO Market Size Market Share by Region (2021-2026)
Table 20. Global Aptamer CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Aptamer CDMO Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Aptamer CDMO Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Aptamer CDMO Market Size Market Share by Country (2021-2026)
Table 24. Americas Aptamer CDMO Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Aptamer CDMO Market Size Market Share by Type (2021-2026)
Table 26. Americas Aptamer CDMO Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Aptamer CDMO Market Size Market Share by Application (2021-2026)
Table 28. APAC Aptamer CDMO Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Aptamer CDMO Market Size Market Share by Region (2021-2026)
Table 30. APAC Aptamer CDMO Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Aptamer CDMO Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Aptamer CDMO Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Aptamer CDMO Market Size Market Share by Country (2021-2026)
Table 34. Europe Aptamer CDMO Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Aptamer CDMO Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Aptamer CDMO Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Aptamer CDMO Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Aptamer CDMO Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Aptamer CDMO
Table 40. Key Market Challenges & Risks of Aptamer CDMO
Table 41. Key Industry Trends of Aptamer CDMO
Table 42. Global Aptamer CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Aptamer CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Aptamer CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Aptamer CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. AMSBIO Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 47. AMSBIO Aptamer CDMO Product Offered
Table 48. AMSBIO Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. AMSBIO Main Business
Table 50. AMSBIO Latest Developments
Table 51. Aptagen Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 52. Aptagen Aptamer CDMO Product Offered
Table 53. Aptagen Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Aptagen Main Business
Table 55. Aptagen Latest Developments
Table 56. Aptamer Group Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 57. Aptamer Group Aptamer CDMO Product Offered
Table 58. Aptamer Group Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Aptamer Group Main Business
Table 60. Aptamer Group Latest Developments
Table 61. PORTON Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 62. PORTON Aptamer CDMO Product Offered
Table 63. PORTON Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. PORTON Main Business
Table 65. PORTON Latest Developments
Table 66. Base Pair Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 67. Base Pair Aptamer CDMO Product Offered
Table 68. Base Pair Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Base Pair Main Business
Table 70. Base Pair Latest Developments
Table 71. Base Pair Biotechnologies Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 72. Base Pair Biotechnologies Aptamer CDMO Product Offered
Table 73. Base Pair Biotechnologies Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Base Pair Biotechnologies Main Business
Table 75. Base Pair Biotechnologies Latest Developments
Table 76. Cambio Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 77. Cambio Aptamer CDMO Product Offered
Table 78. Cambio Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Cambio Main Business
Table 80. Cambio Latest Developments
Table 81. CD Bioparticles Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 82. CD Bioparticles Aptamer CDMO Product Offered
Table 83. CD Bioparticles Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. CD Bioparticles Main Business
Table 85. CD Bioparticles Latest Developments
Table 86. Creative Biolabs Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 87. Creative Biolabs Aptamer CDMO Product Offered
Table 88. Creative Biolabs Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Creative Biolabs Main Business
Table 90. Creative Biolabs Latest Developments
Table 91. Eurogentec Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 92. Eurogentec Aptamer CDMO Product Offered
Table 93. Eurogentec Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Eurogentec Main Business
Table 95. Eurogentec Latest Developments
Table 96. Novaptech Details, Company Type, Aptamer CDMO Area Served and Its Competitors
Table 97. Novaptech Aptamer CDMO Product Offered
Table 98. Novaptech Aptamer CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Novaptech Main Business
Table 100. Novaptech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Aptamer CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Aptamer CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Aptamer CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Aptamer CDMO Sales Market Share by Country/Region (2025)
Figure 8. Aptamer CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Aptamer CDMO Market Size Market Share by Type in 2025
Figure 10. Aptamer CDMO in Scientific Research
Figure 11. Global Aptamer CDMO Market: Scientific Research (2021-2026) & ($ millions)
Figure 12. Aptamer CDMO in Medical Treatment
Figure 13. Global Aptamer CDMO Market: Medical Treatment (2021-2026) & ($ millions)
Figure 14. Aptamer CDMO in Others
Figure 15. Global Aptamer CDMO Market: Others (2021-2026) & ($ millions)
Figure 16. Global Aptamer CDMO Market Size Market Share by Application in 2025
Figure 17. Global Aptamer CDMO Revenue Market Share by Player in 2025
Figure 18. Global Aptamer CDMO Market Size Market Share by Region (2021-2026)
Figure 19. Americas Aptamer CDMO Market Size 2021-2026 ($ millions)
Figure 20. APAC Aptamer CDMO Market Size 2021-2026 ($ millions)
Figure 21. Europe Aptamer CDMO Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Aptamer CDMO Market Size 2021-2026 ($ millions)
Figure 23. Americas Aptamer CDMO Value Market Share by Country in 2025
Figure 24. United States Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Aptamer CDMO Market Size Market Share by Region in 2025
Figure 29. APAC Aptamer CDMO Market Size Market Share by Type (2021-2026)
Figure 30. APAC Aptamer CDMO Market Size Market Share by Application (2021-2026)
Figure 31. China Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. India Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Aptamer CDMO Market Size Market Share by Country in 2025
Figure 38. Europe Aptamer CDMO Market Size Market Share by Type (2021-2026)
Figure 39. Europe Aptamer CDMO Market Size Market Share by Application (2021-2026)
Figure 40. Germany Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. France Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Aptamer CDMO Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Aptamer CDMO Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Aptamer CDMO Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Aptamer CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 54. APAC Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 55. Europe Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 57. United States Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 58. Canada Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 59. Mexico Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 60. Brazil Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 61. China Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 62. Japan Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 63. Korea Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 65. India Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 66. Australia Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 67. Germany Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 68. France Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 69. UK Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 70. Italy Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 71. Russia Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 72. Egypt Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 73. South Africa Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 74. Israel Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 75. Turkey Aptamer CDMO Market Size 2027-2032 ($ millions)
Figure 76. Global Aptamer CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Aptamer CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Aptamer CDMO Market Size 2027-2032 ($ millions)